RU2013123078A - METHOD FOR PRODUCING BIFIDOGENIC FACTOR - Google Patents

METHOD FOR PRODUCING BIFIDOGENIC FACTOR Download PDF

Info

Publication number
RU2013123078A
RU2013123078A RU2013123078/10A RU2013123078A RU2013123078A RU 2013123078 A RU2013123078 A RU 2013123078A RU 2013123078/10 A RU2013123078/10 A RU 2013123078/10A RU 2013123078 A RU2013123078 A RU 2013123078A RU 2013123078 A RU2013123078 A RU 2013123078A
Authority
RU
Russia
Prior art keywords
producing
bifidogenic factor
sepharose
bifidogenic
factor
Prior art date
Application number
RU2013123078/10A
Other languages
Russian (ru)
Other versions
RU2553513C2 (en
Inventor
Андрей Сергеевич Сухих
Юлия Викторовна Захарова
Алексей Николаевич Волков
Original Assignee
Андрей Сергеевич Сухих
Юлия Викторовна Захарова
Алексей Николаевич Волков
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Андрей Сергеевич Сухих, Юлия Викторовна Захарова, Алексей Николаевич Волков filed Critical Андрей Сергеевич Сухих
Priority to RU2013123078/10A priority Critical patent/RU2553513C2/en
Publication of RU2013123078A publication Critical patent/RU2013123078A/en
Application granted granted Critical
Publication of RU2553513C2 publication Critical patent/RU2553513C2/en

Links

Landscapes

  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Способ получения бифидогенного фактора, отличающийся тем, что в качестве бифидогенного фактора используется дезоксирибонуклеиновая кислота, которая выделяется из накопленной клеточной массы необходимого штамма бифидобактерий в процессе ультразвуковой обработки при частоте 40кГц с последующим отделением супернатанта центрифугированием при 5 тыс. об/мин и хроматографированием с использованием сефарозы (Sepharose) CL-4B.A method of producing a bifidogenic factor, characterized in that deoxyribonucleic acid is used as the bifidogenic factor, which is released from the accumulated cell mass of the required strain of bifidobacteria in the process of ultrasonic treatment at a frequency of 40 kHz, followed by separation of the supernatant by centrifugation at 5 thousand rpm and chromatography using sepharose (Sepharose) CL-4B.

Claims (1)

Способ получения бифидогенного фактора, отличающийся тем, что в качестве бифидогенного фактора используется дезоксирибонуклеиновая кислота, которая выделяется из накопленной клеточной массы необходимого штамма бифидобактерий в процессе ультразвуковой обработки при частоте 40кГц с последующим отделением супернатанта центрифугированием при 5 тыс. об/мин и хроматографированием с использованием сефарозы (Sepharose) CL-4B. A method of producing a bifidogenic factor, characterized in that deoxyribonucleic acid is used as the bifidogenic factor, which is released from the accumulated cell mass of the required strain of bifidobacteria in the process of ultrasonic treatment at a frequency of 40 kHz, followed by separation of the supernatant by centrifugation at 5 thousand rpm and chromatography using sepharose (Sepharose) CL-4B.
RU2013123078/10A 2013-05-20 2013-05-20 Method of obtaining bifidogenic factor RU2553513C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2013123078/10A RU2553513C2 (en) 2013-05-20 2013-05-20 Method of obtaining bifidogenic factor

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2013123078/10A RU2553513C2 (en) 2013-05-20 2013-05-20 Method of obtaining bifidogenic factor

Publications (2)

Publication Number Publication Date
RU2013123078A true RU2013123078A (en) 2014-11-27
RU2553513C2 RU2553513C2 (en) 2015-06-20

Family

ID=53381191

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2013123078/10A RU2553513C2 (en) 2013-05-20 2013-05-20 Method of obtaining bifidogenic factor

Country Status (1)

Country Link
RU (1) RU2553513C2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2738671C1 (en) * 2020-02-26 2020-12-15 Федеральное государственное бюджетное образовательное учреждение высшего образования "Кемеровский медицинский университет" (ФГБОУ ВО КемГМУ) Method for producing and purifying biologically active substance produced by bifidobacteria

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1124033A1 (en) * 1983-02-16 1984-11-15 Предприятие П/Я Г-4740 Method for preparing dna plasmid
RU2123345C1 (en) * 1997-07-31 1998-12-20 Научно-исследовательский институт детского питания Российской Академии сельскохозяйственных наук Agent for disbacteriosis treatment

Also Published As

Publication number Publication date
RU2553513C2 (en) 2015-06-20

Similar Documents

Publication Publication Date Title
MX2021014735A (en) Anti-cd166 antibodies, activatable anti-cd166 antibodies, and methods of use thereof.
MX2019011916A (en) Anti-lag3 antibodies.
WO2012109215A3 (en) Apparatuses and methods for the production of microfibers and nanofibers
WO2016161123A8 (en) Aerogel materials and methods for their production
EP3124635A4 (en) Rolled ferritic stainless-steel plate, process for producing same, and flange component
WO2012106407A3 (en) Diagnostic and therapeutic methods and products related to anxiety disorders
PH12016501366A1 (en) Novel anti-baff antibodies
EP3395839A4 (en) Method for producing cellulose nanofiber dry solid
GB2541150A (en) Improvements in and relating to sample collection
WO2015112293A8 (en) Synthesis of molecular sieves having mww framework structure
GEP20227382B (en) Anti-coagulation factor xi antibodies
WO2016043462A3 (en) Method for preparing calcobutrol
MX2018000221A (en) Acoustic mixing for auto granulation.
WO2015138532A3 (en) Methods for the treatment of kidney fibrosis
MX2016009364A (en) Process for fractionation of oligosaccharides from agri-waste.
EP3109260A4 (en) Aminosilane terminal modifier to which functional group has been introduced, method for producing terminal-modified conjugated diene polymer using the aminosilane terminal modifier, and terminal-modified conjugated diene polymer produced according to the method
SG10201807572PA (en) Robust antibody purification
UY36553A (en) METHOD AND APPLIANCE TO INCREASE THE CONCENTRATION OF A FRACTION CONTAINING SOLUBLE CARBOHYDRATES, A FRACTION CONTAINING SOLUBLE CARBOHYDRATES, A SOLID FRACTION AND ITS USE
EP3089479A4 (en) Method for producing intravascular ultrasonic transducer and structure thereof
MX2016005046A (en) Process for separating methacrolein.
CY1115803T1 (en) MEASURES AND METHODS OF ACTION OF CELLULAR IMMUNE TREATMENT AGAINST CANCER USING VULNERABLE VOLUME KNOWLEDGE CELLS
CO2017000010A2 (en) Process for the preparation of 3-hydroxypicolinic acids
MX2017011447A (en) Recovery and/or reuse of palladium catalyst after a suzuki coupling.
RU2013123078A (en) METHOD FOR PRODUCING BIFIDOGENIC FACTOR
MX2017000785A (en) Wood acetylation process.

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20160521

NF4A Reinstatement of patent

Effective date: 20170220

MM4A The patent is invalid due to non-payment of fees

Effective date: 20180521